These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 35874375)

  • 21. Is the R&D Expenditure of Listed Companies Green? Evidence from China's A-Share Market.
    Li B; Li L; Pi T
    Int J Environ Res Public Health; 2022 Sep; 19(19):. PubMed ID: 36231273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Research on the impact mechanism of heterogeneous environmental regulation on enterprise green technology innovation.
    Wang L; Long Y; Li C
    J Environ Manage; 2022 Nov; 322():116127. PubMed ID: 36067664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of economic policy uncertainty on firms' investment in innovation: Evidence from Chinese listed firms.
    Kun W; Hu X; Liu F
    PLoS One; 2022; 17(11):e0272983. PubMed ID: 36378624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Economic benefits of construction waste recycling enterprises under tax incentive policies.
    Liu J; Gong E; Wang X
    Environ Sci Pollut Res Int; 2022 Feb; 29(9):12574-12588. PubMed ID: 33856632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tax incentives and environmental, social, and governance performance: empirical evidence from China.
    Zhu N; Zhou Y; Zhang S; Yan J
    Environ Sci Pollut Res Int; 2023 Apr; 30(19):54899-54913. PubMed ID: 36881223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of Monetary Policy Uncertainty on R&D Investment Smoothing Behavior of Pharmaceutical Manufacturing Enterprises: Empirical Research Based on a Threshold Regression Model.
    Yang J; Wang L; Sun Z; Zhu F; Guo Y; Shen Y
    Int J Environ Res Public Health; 2021 Nov; 18(21):. PubMed ID: 34770073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessing the impact of green tax reforms on corporate environmental performance and economic growth: do green reforms promote the environmental performance in heavily polluted enterprises?
    Shi X; Jiang Z; Bai D; Fahad S; Irfan M
    Environ Sci Pollut Res Int; 2023 Apr; 30(19):56054-56072. PubMed ID: 36913016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of climate policy uncertainty on corporate pollution Emissions--Evidence from China.
    Wang C; Wang H; Bai Y; Shan J; Nie P; Chen Y
    J Environ Manage; 2024 Jul; 363():121426. PubMed ID: 38852421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The influence of "industry policy" and "financial institution" configuration effect on innovation performance of China's biomedical industry-based on necessary condition analysis and qualitative comparative analysis.
    Zhang Y
    Front Med (Lausanne); 2023; 10():1297495. PubMed ID: 38259851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A dynamic panel threshold model analysis on heterogeneous environmental regulation, R&D investment, and enterprise green total factor productivity.
    Liu L; Ren R; Cui K; Song L
    Sci Rep; 2024 Mar; 14(1):5208. PubMed ID: 38433283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enterprise innovation and audit pricing: An evidence study from China's A-share listed companies.
    Zhang L; Su W; Liu S
    PLoS One; 2024; 19(3):e0300137. PubMed ID: 38466695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Research on wind power industrial policies' functional mechanism to the quality of enterprise innovation.
    Wang X; Tao Z; Pan G; Zou H; Xie Y; Li X
    Environ Sci Pollut Res Int; 2023 Mar; 30(12):34350-34362. PubMed ID: 36509957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peer effect of enterprise innovation: Empirical evidence from China.
    Liu L; Yang J; Zheng M; Jin L
    Front Psychol; 2022; 13():921127. PubMed ID: 36389507
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of green innovation on the carbon performance of Chinese manufacturing enterprises: Moderating role of internal governance.
    Ju W; Jin S
    Heliyon; 2024 May; 10(10):e31272. PubMed ID: 38803929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Executive pharmaceutical background, R&D investment and corporate innovation performance.
    Zhang L; Li S; Wu M
    Am J Transl Res; 2023; 15(11):6576-6586. PubMed ID: 38074834
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Green credit guideline and enterprise export green-sophistication.
    Zhou C; Sun Z; Qi S; Li Y; Gao H
    J Environ Manage; 2023 Jun; 336():117648. PubMed ID: 36871455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of National Centralized Drug Procurement policy on chemical pharmaceutical enterprises' R&D investment: a difference-in-differences analysis in China.
    Li J; Zhang X; Wang R; Cao K; Wan L; Ren X; Ding J; Li W
    Front Public Health; 2024; 12():1402581. PubMed ID: 39011324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Golden Tax Project III and green innovation: evidence from heavily polluting enterprises in China.
    Zhang W; Tian Z; Chen Z
    Environ Sci Pollut Res Int; 2023 Apr; 30(17):49618-49631. PubMed ID: 36780074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Research on the Impact of Industrial Policy on the Innovation Behavior of Strategic Emerging Industries.
    Yang W; Wang X; Zhou D
    Behav Sci (Basel); 2024 Apr; 14(4):. PubMed ID: 38667142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Government environmental protection subsidies, environmental tax collection, and green innovation: evidence from listed enterprises in China.
    Jiang Z; Xu C; Zhou J
    Environ Sci Pollut Res Int; 2023 Jan; 30(2):4627-4641. PubMed ID: 35971054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.